Neurostimulation System Significantly Reduces Tinnitus
By HospiMedica International staff writers Posted on 26 Oct 2020 |

Image: Simultaneously stimulating the tongue and auditory system can treat tinnitus (Photo courtesy of Neuromod Devices)
A neuromodulation device that combines sound and electrical stimulation of the tongue can significantly reduce tinnitus symptoms.
The Neuromod Devices (Dublin, Ireland) Lenire system consists of a pair of Bluetooth wireless headphones that deliver sequences of audio tones (layered with wideband noise) to both ears, which is combined with electrical stimulation pulses delivered to 32 electrodes on the tip of the tongue by a proprietary device called the Tonguetip. Timing, intensity, and delivery of the stimuli are self-controlled by an easy-to-use handheld controller. Before first using the device, it is configured to a patient’s hearing profile and optimized to the patient’s sensitivity level for tongue stimulation.
In a study of the Lenire, 326 participants were instructed to use the device for 60 minutes daily for a period of 12 weeks. When treatment was completed, the participants returned their devices and were assessed at three follow-up visits for up to 12 months. About two-thirds of the participants affirmed they had benefited from using the device, with many experiencing sustained benefit 12 months post-treatment, and 77.8% said they would recommend it for other people with tinnitus.
“This study tracked the post-treatment therapeutic effects for 12 months, which is a first for the tinnitus field in evaluating the long-term outcomes of a medical device approach,” said Hubert Lim, PhD, of the University of Minnesota, and chief scientific officer of Neuromod Devices. “The outcomes are very exciting, and I look forward to continuing our work to develop a bimodal neuromodulation treatment to help as many tinnitus sufferers as possible.”
Tinnitus is the perception of sound within the human ear when no actual sound is present. It is not a disease, but a condition that can result from a wide range of underlying causes, including neurological damage, ear infections, oxidative stress, foreign objects, nasal allergies, wax build-up, and exposure to loud sounds. While it may be an accompaniment of sensorineural hearing loss or congenital hearing loss, or a side effect of certain medications, the most common cause is noise-induced hearing loss. Tinnitus is common, with about 20% of people between 55 and 65 years old report symptoms on a general health questionnaire, and 11.8% on more detailed tinnitus-specific questionnaires.
Related Links:
Neuromod Devices
The Neuromod Devices (Dublin, Ireland) Lenire system consists of a pair of Bluetooth wireless headphones that deliver sequences of audio tones (layered with wideband noise) to both ears, which is combined with electrical stimulation pulses delivered to 32 electrodes on the tip of the tongue by a proprietary device called the Tonguetip. Timing, intensity, and delivery of the stimuli are self-controlled by an easy-to-use handheld controller. Before first using the device, it is configured to a patient’s hearing profile and optimized to the patient’s sensitivity level for tongue stimulation.
In a study of the Lenire, 326 participants were instructed to use the device for 60 minutes daily for a period of 12 weeks. When treatment was completed, the participants returned their devices and were assessed at three follow-up visits for up to 12 months. About two-thirds of the participants affirmed they had benefited from using the device, with many experiencing sustained benefit 12 months post-treatment, and 77.8% said they would recommend it for other people with tinnitus.
“This study tracked the post-treatment therapeutic effects for 12 months, which is a first for the tinnitus field in evaluating the long-term outcomes of a medical device approach,” said Hubert Lim, PhD, of the University of Minnesota, and chief scientific officer of Neuromod Devices. “The outcomes are very exciting, and I look forward to continuing our work to develop a bimodal neuromodulation treatment to help as many tinnitus sufferers as possible.”
Tinnitus is the perception of sound within the human ear when no actual sound is present. It is not a disease, but a condition that can result from a wide range of underlying causes, including neurological damage, ear infections, oxidative stress, foreign objects, nasal allergies, wax build-up, and exposure to loud sounds. While it may be an accompaniment of sensorineural hearing loss or congenital hearing loss, or a side effect of certain medications, the most common cause is noise-induced hearing loss. Tinnitus is common, with about 20% of people between 55 and 65 years old report symptoms on a general health questionnaire, and 11.8% on more detailed tinnitus-specific questionnaires.
Related Links:
Neuromod Devices
Latest Patient Care News
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
- Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases
- Wearable Cardioverter Defibrillator System Protects Patients at Risk of Sudden Cardiac Arrest
Channels
Critical Care
view channel
Smart Bandage Monitors Chronic Wounds in Human Patients
A future smart bandage, envisioned as a "lab on skin," could assist both patients and caregivers by not only monitoring chronic wounds but also delivering treatment and accelerating the healing process... Read more
AI Identifies Patients with Increased Lung Cancer Risk Up To 4 Months Earlier
Earlier diagnosis plays a crucial role in improving the prognosis of cancer, as delays in starting therapy are associated with decreased survival rates. In most cases, cancer is first identified when symptoms... Read more
AI Algorithm Identifies High-Risk Heart Patients
Hypertrophic cardiomyopathy (HCM) is a complex condition characterized by the thickening of the heart muscle, which impairs the heart's ability to pump blood effectively. This forces the heart to work... Read more
Next Gen Hemodynamic Monitoring Solution Provides AI-Driven Clinical Decision Support
A new cutting-edge hemodynamic monitoring platform, equipped with predictive artificial intelligence (AI)-based algorithms, is designed to help clinicians proactively manage blood pressure fluctuations... Read moreSurgical Techniques
view channel
DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment
One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more